4
Changes in Ownership
RenovoRx, Inc. Filed Acc 0001493152-26-042650
Chief Financial Officer acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| VOLL MARK Chief Financial Officer | 2026-09-10 | Grant or award | +80,000 | 222,380 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…